BNTC

MKT CAP:$372M

Benitec Biopharma Ltd ADR

Market Cap

$372M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$10.55-$2.04 (-16.17%)

Jun 5, 2026

52W High $16.5652W Low $10.06

Company Details

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create me...

CEO

—

IPO Date

Aug 18, 2015

Website

benitec.com

Key Metrics TTM (AUD)

Revenue

AUD 556.0K

- YoY

Net Income

-AUD 49M

EPS (Diluted)

Free Cash Flow

-AUD 21M

Revenue / Share

AUD 0.01

Gross Margin

-14.2%

Operating Margin

-9701.1%

Net Margin

-8792.1%

FCF Margin

-3704.1%

P/S

P/E

Earnings Reports

Q4 2026

Sep 22, 2026

PENDING

Q3 2026

May 14, 2026

AUD 0

Q2 2026

Feb 12, 2026

AUD 0

Q1 2026

Nov 14, 2025

AUD 0

FY 2025

Sep 22, 2025

AUD 0-100.0%

Revenue & Profitability (AUD)

Operating Cash Flow (AUD)

CapEx Spend (AUD)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (AUD)

OpEx Breakdown (AUD)

War Chest (AUD)

Shares Outstanding

Revenue Per Employee (AUD)

Revenue / Employee